- Report
- February 2024
- 175 Pages
Global
From €4834EUR$5,000USD£4,152GBP
- Report
- February 2024
- 126 Pages
Global
From €4592EUR$4,750USD£3,945GBP
- Report
- May 2021
- 70 Pages
United States
From €657EUR$680USD£565GBP
€822EUR$850USD£706GBP
- Report
- August 2022
- 175 Pages
Global
From €9185EUR$9,500USD£7,889GBP
- Report
- January 2020
- 76 Pages
United States
From €6763EUR$6,995USD£5,809GBP
- Report
- February 2023
- 79 Pages
Middle East, Africa
From €1450EUR$1,500USD£1,246GBP
Kerydin is a brand of antifungal medication used to treat fungal infections of the toenails and fingernails. It is a topical solution that is applied directly to the affected area. Kerydin is part of the larger market of infectious diseases drugs, which are used to treat a variety of bacterial, viral, and fungal infections. These drugs are used to treat a wide range of conditions, from the common cold to more serious illnesses such as HIV and tuberculosis.
Kerydin is one of many antifungal medications available on the market. Other antifungal drugs include Lamisil, Sporanox, and Diflucan. These drugs are used to treat fungal infections of the skin, nails, and other areas of the body. In addition to antifungal medications, there are also antibiotics, antivirals, and other drugs used to treat infectious diseases.
The companies in the Kerydin market include Novartis, Pfizer, Merck, and Johnson & Johnson. These companies produce and market a variety of drugs used to treat infectious diseases. Show Less Read more